GPT Infraprojects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 4:21 pm

Quick Insight

GPT Infraprojects Ltd, operating in the cement products industry, currently trades at a price of ₹115 with a market capitalization of ₹1,457 Cr. The stock shows a P/E ratio of 16.8, ROE of 19.6%, ROCE of 21.9%, and an OPM of 12%. With a net profit of ₹74 Cr and reserves amounting to ₹397 Cr, the company carries borrowings of ₹129 Cr. Notably, GPT Infraprojects Ltd demonstrates a healthy ICR of 3.90x, indicating a strong ability to meet its interest obligations. However, the negative CCC of -222 days warrants attention, suggesting potential issues with managing cash flow efficiently. Investors should closely monitor the company's operational efficiency and liquidity management strategies to ensure sustained financial health.

Competitors of GPT Infraprojects Ltd

All Competitor Stocks of GPT Infraprojects Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:10 am

Below is a detailed analysis of the quarterly data for GPT Infraprojects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 313.00 Cr.. The value appears to be declining and may need further review. It has decreased from 381.00 Cr. (Mar 2025) to 313.00 Cr., marking a decrease of 68.00 Cr..
• For Expenses, as of Jun 2025, the value is 276.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 342.00 Cr. (Mar 2025) to 276.00 Cr., marking a decrease of 66.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 12.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 8.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2025) to 33.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 25.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.86. The value appears to be declining and may need further review. It has decreased from 1.92 (Mar 2025) to 1.86, marking a decrease of 0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:46 pm

Growth

Last Updated: September 5, 2025, 5:15 am

Balance Sheet

Last Updated: July 25, 2025, 3:09 pm

Below is a detailed analysis of the balance sheet data for GPT Infraprojects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2024) to 126.00 Cr., marking an increase of 68.00 Cr..
• For Reserves, as of Mar 2025, the value is 397.00 Cr.. The value appears strong and on an upward trend. It has increased from 244.00 Cr. (Mar 2024) to 397.00 Cr., marking an increase of 153.00 Cr..
• For Borrowings, as of Mar 2025, the value is 129.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 193.00 Cr. (Mar 2024) to 129.00 Cr., marking a decrease of 64.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 289.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 231.00 Cr. (Mar 2024) to 289.00 Cr., marking an increase of 58.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 941.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 726.00 Cr. (Mar 2024) to 941.00 Cr., marking an increase of 215.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 164.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2024) to 164.00 Cr., marking an increase of 29.00 Cr..
• For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 9.00 Cr..
• For Other Assets, as of Mar 2025, the value is 736.00 Cr.. The value appears strong and on an upward trend. It has increased from 566.00 Cr. (Mar 2024) to 736.00 Cr., marking an increase of 170.00 Cr..
• For Total Assets, as of Mar 2025, the value is 941.00 Cr.. The value appears strong and on an upward trend. It has increased from 726.00 Cr. (Mar 2024) to 941.00 Cr., marking an increase of 215.00 Cr..

Notably, the Reserves (397.00 Cr.) exceed the Borrowings (129.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for GPT Infraprojects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 9.94. This value is within the healthy range. It has increased from 5.40 (Mar 23) to 9.94, marking an increase of 4.54.
• For Diluted EPS (Rs.), as of Mar 24, the value is 9.94. This value is within the healthy range. It has increased from 5.40 (Mar 23) to 9.94, marking an increase of 4.54.
• For Cash EPS (Rs.), as of Mar 24, the value is 12.43. This value is within the healthy range. It has increased from 8.12 (Mar 23) to 12.43, marking an increase of 4.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 51.67. It has increased from 47.65 (Mar 23) to 51.67, marking an increase of 4.02.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 51.67. It has increased from 47.65 (Mar 23) to 51.67, marking an increase of 4.02.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 175.48. It has increased from 139.41 (Mar 23) to 175.48, marking an increase of 36.07.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 21.94. This value is within the healthy range. It has increased from 15.83 (Mar 23) to 21.94, marking an increase of 6.11.
• For PBIT / Share (Rs.), as of Mar 24, the value is 19.23. This value is within the healthy range. It has increased from 12.61 (Mar 23) to 19.23, marking an increase of 6.62.
• For PBT / Share (Rs.), as of Mar 24, the value is 13.60. This value is within the healthy range. It has increased from 6.18 (Mar 23) to 13.60, marking an increase of 7.42.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 9.71. This value is within the healthy range. It has increased from 4.90 (Mar 23) to 9.71, marking an increase of 4.81.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.94. This value is within the healthy range. It has increased from 5.40 (Mar 23) to 9.94, marking an increase of 4.54.
• For PBDIT Margin (%), as of Mar 24, the value is 12.50. This value is within the healthy range. It has increased from 11.35 (Mar 23) to 12.50, marking an increase of 1.15.
• For PBIT Margin (%), as of Mar 24, the value is 10.95. This value is within the healthy range. It has increased from 9.04 (Mar 23) to 10.95, marking an increase of 1.91.
• For PBT Margin (%), as of Mar 24, the value is 7.75. This value is below the healthy minimum of 10. It has increased from 4.43 (Mar 23) to 7.75, marking an increase of 3.32.
• For Net Profit Margin (%), as of Mar 24, the value is 5.53. This value is within the healthy range. It has increased from 3.51 (Mar 23) to 5.53, marking an increase of 2.02.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.66. This value is below the healthy minimum of 8. It has increased from 3.87 (Mar 23) to 5.66, marking an increase of 1.79.
• For Return on Networth / Equity (%), as of Mar 24, the value is 19.11. This value is within the healthy range. It has increased from 11.32 (Mar 23) to 19.11, marking an increase of 7.79.
• For Return on Capital Employeed (%), as of Mar 24, the value is 30.96. This value is within the healthy range. It has increased from 20.51 (Mar 23) to 30.96, marking an increase of 10.45.
• For Return On Assets (%), as of Mar 24, the value is 7.94. This value is within the healthy range. It has increased from 4.01 (Mar 23) to 7.94, marking an increase of 3.93.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 23) to 0.08, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.62. This value is within the healthy range. It has decreased from 0.88 (Mar 23) to 0.62, marking a decrease of 0.26.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.35. It has increased from 1.09 (Mar 23) to 1.35, marking an increase of 0.26.
• For Current Ratio (X), as of Mar 24, the value is 1.43. This value is below the healthy minimum of 1.5. It has increased from 1.30 (Mar 23) to 1.43, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 24, the value is 1.06. This value is within the healthy range. It has increased from 1.02 (Mar 23) to 1.06, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.35. This value is below the healthy minimum of 4. It has decreased from 0.63 (Mar 23) to 0.35, marking a decrease of 0.28.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 35.19. This value is within the healthy range. It has increased from 32.42 (Mar 23) to 35.19, marking an increase of 2.77.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 27.64. This value is within the healthy range. It has increased from 20.32 (Mar 23) to 27.64, marking an increase of 7.32.
• For Earning Retention Ratio (%), as of Mar 24, the value is 64.81. This value is within the healthy range. It has decreased from 67.58 (Mar 23) to 64.81, marking a decrease of 2.77.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 72.36. This value exceeds the healthy maximum of 70. It has decreased from 79.68 (Mar 23) to 72.36, marking a decrease of 7.32.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.90. This value is within the healthy range. It has increased from 2.46 (Mar 23) to 3.90, marking an increase of 1.44.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.73. This value is below the healthy minimum of 3. It has increased from 1.76 (Mar 23) to 2.73, marking an increase of 0.97.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,060.45. It has increased from 473.47 (Mar 23) to 1,060.45, marking an increase of 586.98.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.04. This value is within the healthy range. It has increased from 0.58 (Mar 23) to 1.04, marking an increase of 0.46.
• For EV / EBITDA (X), as of Mar 24, the value is 8.31. This value is within the healthy range. It has increased from 5.14 (Mar 23) to 8.31, marking an increase of 3.17.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 23) to 0.88, marking an increase of 0.57.
• For Retention Ratios (%), as of Mar 24, the value is 64.80. This value is within the healthy range. It has decreased from 67.57 (Mar 23) to 64.80, marking a decrease of 2.77.
• For Price / BV (X), as of Mar 24, the value is 2.97. This value is within the healthy range. It has increased from 0.91 (Mar 23) to 2.97, marking an increase of 2.06.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 23) to 0.88, marking an increase of 0.57.
• For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 23) to 0.06, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness